Infusion Brands International, Inc. (INBI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Infusion Brands International, Inc. (INBI) trades at $0.00 with AI Score 65/100 (Grade B+). Infusion Brands International, Inc. operates in the consumer products sector, focusing on direct-to-consumer marketing. Market cap: $18,146, Sector: Consumer defensive.
Last analyzed: Mar 18, 2026Analyst Coverage for INBI: INBI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates INBI against Consumer Defensive peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
INBI: 2/4 perspectives are bullish. Dominant signal: Izzy Englander bullish.
Infusion Brands International, Inc. (INBI) Consumer Business Overview
Infusion Brands International, Inc. (INBI) builds and markets consumer brands through direct-to-consumer channels, featuring power tools under DUALTOOLS, kitchenware under Ronco, and dieting plans via eDiets.com. The company faces challenges in a competitive market with a negative profit margin of -38.2%.
What Is the Investment Thesis for INBI?
Infusion Brands International, Inc. presents a challenging investment case given its negative profit margin of -38.2%. The company's direct-to-consumer model offers potential for growth, but its ability to achieve profitability is uncertain. Key value drivers include successful brand management and effective marketing strategies. Upcoming catalysts include potential product launches and expansion of its eDiets.com platform. Potential risks include intense competition in the consumer products market and the need for significant marketing investments to maintain brand visibility. Investors should closely monitor the company's ability to improve its financial performance and achieve sustainable profitability by the end of 2027.
Based on FMP financials and quantitative analysis
INBI Key Highlights
- Infusion Brands International, Inc. operates with a small team of 47 employees.
- The company's gross margin stands at 40.3%, indicating a reasonable markup on its products.
- The company's profit margin is -38.2%, reflecting significant challenges in achieving profitability.
- The company's beta is -0.23, suggesting a low correlation with overall market movements.
- The company markets products under the DUALTOOLS, Ronco, and DOC brands, targeting diverse consumer needs.
Who Are INBI's Competitors?
INBI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $60.68 | +4.40% | $3.61B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
| NBBTF Natural Beauty Bio-Technology Limited | $0.06 | +0.00% | $122.13M | 57 |
| CL Colgate-Palmolive Company | $89.07 | -0.36% | $71.27B | 57 |
| LIOPF Lion Corporation | $11.51 | +0.00% | $3.18B | 54 |
| IPAR Inter Parfums, Inc. | $102.22 | +2.07% | $3.27B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are INBI's Key Strengths?
- Established brands like Ronco.
- Direct-to-consumer distribution model.
- Diverse product portfolio.
- eDiets.com platform providing recurring revenue.
What Are INBI's Weaknesses?
- Negative profit margin.
- Limited market capitalization.
- Dependence on effective marketing campaigns.
- Small employee base.
What Could Drive INBI Stock Higher?
- Potential product launches under the Ronco brand in Q4 2026, targeting the holiday season.
- Expansion of the eDiets.com platform with new features and personalized plans throughout 2026.
- Strategic marketing campaigns to increase brand awareness and customer acquisition in 2026.
What Are the Key Risks for INBI?
- Intense competition in the consumer products industry could impact market share.
- Economic downturns may reduce consumer spending on discretionary items.
- Negative profit margin poses a significant challenge to long-term sustainability.
- Dependence on effective marketing campaigns to drive sales and brand awareness.
- Limited financial disclosure due to OTC listing increases investment risk.
What Are the Growth Opportunities for INBI?
- Expansion of eDiets.com: The online dieting and lifestyle market is projected to reach $27.7 billion by 2028. Infusion Brands can capitalize on this growth by enhancing its eDiets.com platform with personalized plans, digital tools, and community features. This expansion can attract new subscribers and increase recurring revenue, strengthening its position in the health and wellness sector.
- Product Innovation in Kitchenware: The global kitchenware market is expected to reach $78.5 billion by 2027. Infusion Brands can leverage its Ronco brand to introduce innovative kitchen gadgets and appliances that cater to modern cooking trends. By focusing on convenience, efficiency, and unique features, the company can attract a wider customer base and increase sales in this segment.
- Strategic Partnerships: Collaborating with complementary businesses, such as fitness apps or health food brands, can expand Infusion Brands' reach and customer base. These partnerships can create cross-promotional opportunities and bundled offerings, driving revenue growth and brand awareness. The timeline for establishing these partnerships is within the next 12-18 months.
- International Market Expansion: Emerging markets offer significant growth potential for consumer products. Infusion Brands can explore opportunities to expand its direct-to-consumer model into new regions, tailoring its product offerings and marketing strategies to local preferences. This expansion can diversify revenue streams and reduce reliance on domestic markets, with initial focus on Asian markets by 2027.
- Enhancing Digital Marketing Capabilities: Investing in advanced digital marketing technologies and strategies can improve customer acquisition and retention. By leveraging data analytics, personalized advertising, and social media engagement, Infusion Brands can optimize its marketing campaigns and increase conversion rates. This ongoing effort can drive sustainable growth and improve brand loyalty.
What Opportunities Does INBI Have?
- Expansion into new international markets.
- Product innovation and development.
- Strategic partnerships and collaborations.
- Growth of the online dieting and lifestyle market.
What Threats Does INBI Face?
- Intense competition in the consumer products industry.
- Changing consumer preferences.
- Economic downturns affecting consumer spending.
- Increased marketing costs and customer acquisition challenges.
What Are INBI's Competitive Advantages?
- Established brands like Ronco with customer recognition.
- Direct-to-consumer model allowing for direct customer relationships.
- Proprietary products and unique offerings.
- Subscription-based revenue from eDiets.com providing recurring income.
What Does INBI Do?
Infusion Brands International, Inc. develops and markets consumer products through direct-to-consumer marketing channels. Founded with the aim of creating and scaling brands through efficient online marketing, the company has evolved to offer a diverse range of products. Its brand portfolio includes DUALTOOLS, offering power tools; Ronco, specializing in kitchen products; and DOC, providing cloths. Additionally, Infusion Brands operates eDiets.com, a website offering dieting and lifestyle maintenance plans, products, and services. The company's strategy centers on leveraging direct-to-consumer channels to reach customers internationally, bypassing traditional retail distribution. Based in Clearwater, Florida, Infusion Brands focuses on building brand awareness and driving sales through targeted marketing campaigns and online platforms. However, the company faces challenges in maintaining profitability, as reflected in its negative profit margin. Its success hinges on effective marketing, product innovation, and adapting to changing consumer preferences in the competitive consumer products market.
What Products and Services Does INBI Offer?
- Develop and market consumer products through direct-to-consumer channels.
- Offer power tools under the DUALTOOLS brand.
- Provide kitchen products under the Ronco brand.
- Market cloths under the DOC brand.
- Operate eDiets.com, a website for dieting and lifestyle maintenance plans.
- Utilize international marketing channels to reach customers.
How Does INBI Make Money?
- Direct-to-consumer sales through online platforms.
- Brand building and marketing of proprietary products.
- Subscription-based revenue model through eDiets.com.
- International distribution of consumer goods.
What Industry Does INBI Operate In?
Infusion Brands International, Inc. operates within the competitive household and personal products industry. This sector is characterized by established players and evolving consumer preferences. The direct-to-consumer model allows for targeted marketing and direct customer engagement. The industry is influenced by trends such as e-commerce growth, demand for innovative products, and health and wellness trends. Competitors include companies like AVRW, BGEM, FITSF, GYSN, and KPOC. Infusion Brands needs to differentiate itself through effective branding and product innovation to capture market share.
Who Are INBI's Key Customers?
- Homeowners and DIY enthusiasts seeking power tools.
- Consumers looking for innovative kitchen gadgets and appliances.
- Individuals interested in dieting and lifestyle maintenance plans.
- Customers seeking cleaning cloths and related products.
INBI Financials
INBI Latest News
No recent news available for INBI.
INBI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for INBI.
Price Targets
Wall Street price target analysis for INBI.
INBI MoonshotScore
What does this score mean?
The MoonshotScore rates INBI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Shadron Lee Stastney
Managing Director
Shadron Lee Stastney serves as the Managing Director of Infusion Brands International, Inc. His leadership is crucial in guiding the company's strategic direction and overseeing its operations. With a focus on direct-to-consumer marketing, Stastney is responsible for driving brand growth and expanding the company's market presence. His experience in the consumer products sector is essential for navigating the competitive landscape and achieving sustainable growth.
Track Record: Since taking on the role of Managing Director, Shadron Lee Stastney has focused on streamlining operations and optimizing marketing strategies. Key milestones include the expansion of the eDiets.com platform and the introduction of new products under the Ronco brand. His leadership is aimed at improving the company's financial performance and enhancing shareholder value.
INBI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Infusion Brands International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not provide regular financial reporting, increasing the risk for investors. Unlike NYSE or NASDAQ listings, which require stringent listing standards and ongoing compliance, OTC Other companies face fewer regulatory requirements, resulting in less transparency and potentially higher volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in INBI.
- Low trading volume and liquidity can lead to price volatility.
- The OTC Other tier indicates a higher risk of fraud or mismanagement.
- Lack of regulatory oversight compared to listed exchanges.
- Potential for delisting or trading suspension due to non-compliance.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review any available news articles or press releases about the company.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Check for any regulatory actions or legal issues involving the company.
- Established brands like Ronco may indicate some level of legitimacy.
- Direct-to-consumer business model with potential for customer engagement.
- The company has been in operation for several years.
- Presence of a management team with experience in the consumer products sector.
INBI Consumer Defensive Stock FAQ
What does Infusion Brands International, Inc. do?
Infusion Brands International, Inc. is a consumer products company that builds and markets brands through direct-to-consumer channels. The company's portfolio includes power tools under the DUALTOOLS brand, kitchen products under the Ronco brand, and cloths under the DOC brand. Additionally, Infusion Brands operates eDiets.com, a website offering dieting and lifestyle maintenance plans, products, and services. The company focuses on leveraging online marketing and direct sales to reach customers internationally, bypassing traditional retail distribution.
What do analysts say about INBI stock?
As of March 18, 2026, there is limited analyst coverage for Infusion Brands International, Inc. due to its OTC listing and small market capitalization. Key valuation metrics, such as P/E ratio, are not meaningful due to the company's negative earnings. Growth considerations include the potential for revenue growth through successful marketing campaigns and product innovation. Investors should conduct thorough due diligence and consider the risks associated with investing in OTC stocks before making any investment decisions.
What are the main risks for INBI?
The main risks for Infusion Brands International, Inc. include its negative profit margin, which poses a significant challenge to long-term sustainability. The company also faces intense competition in the consumer products industry, requiring significant marketing investments to maintain brand visibility. Additionally, the OTC listing and limited financial disclosure increase investment risk. Economic downturns could also impact consumer spending on discretionary items, affecting the company's revenue.
What are the key factors to evaluate for INBI?
Infusion Brands International, Inc. (INBI) holds an AI score of 65/100 (moderate). Not financial advice.
How frequently does INBI data refresh on this page?
INBI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven INBI's recent stock price performance?
Infusion Brands International, Inc. (INBI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands like Ronco. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider INBI overvalued or undervalued right now?
Valuing Infusion Brands International, Inc. (INBI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying INBI?
Before investing in Infusion Brands International, Inc. (INBI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing and lack of analyst coverage.
- Financial data based on available information and may not be comprehensive.